Conditioning Electrical Stimulation to Improve Outcomes in Carpal Tunnel Syndrome

  • STATUS
    Recruiting
  • End date
    Jan 1, 2023
  • participants needed
    60
  • sponsor
    University of Alberta
Updated on 9 May 2021
conservative management
nerve conduction
grip
carpal tunnel release
numbness
nerve conduction study

Summary

Carpal tunnel syndrome is common, identified in 3% of the general population. Symptoms including numbness and pain are due to compression of the median nerve as it travels through a tunnel entering the wrist and can result in weakened grip strength and poor dexterity. Despite surgical release, nerve damage due to chronic compression often cannot be completely reversed, with resulting sensorimotor deficits. Postoperative electrical stimulation (ES) has been well-reported to improve nerve regeneration and is currently standard of practice at our institution. Investigators of this study have recently shown in an animal model that by changing the timing of the ES from postoperative to preoperative, this "conditioning" electrical stimulation (CES) significantly improves nerve regeneration.

Patients with severe carpal tunnel syndrome will be identified in plastic surgery clinics. Patients who consent to participating will undergo baseline testing including nerve conduction studies, sensory evaluation, motor testing, and patient-reported outcomes. Participants will be randomized to three groups: i) CES, ii) postoperative ES, and iii) no ES. CES will be delivered in clinic by placing a percutaneous needle alongside the median nerve, and stimulation will be delivered for one hour, with patient comfort dictating the voltage of stimulation. At the completion of one hour, the needle will be removed, and a standard carpal tunnel release will be performed by their plastic surgeon 4-7 days later. Patients will the second cohort will undergo postoperative ES immediately following their carpal tunnel release, using the same stimulation parameters as CES. The third cohort will receive only carpal tunnel release without stimulation.In all patients, sensory and motor reinnervation, using the same testing modalities as preoperative assessment, will be evaluated at 3, 6, and 12 months post-operative.

Description

Background: Carpal tunnel syndrome (CTS) is the most common compression neuropathy, with a population prevalence of 3%. One quarter of these patients have severe symptoms that necessitate surgical release. Our lab has previously demonstrated that electrical stimulation (ES) at 20Hz for 1 hour immediately following carpal tunnel release significantly improved terminal motor latency, sensory nerve conduction (1). Postoperative electrical stimulation enhances regeneration locally at the site of injury(2); by contrast, the conditioning lesion improves the rate of regeneration along the entire distal stump. The traditional conditioning lesion refers to a purposeful crush injury delivered to a nerve prior to its transection and repair. Despite 40 years of promising research at the bench, describing the conditioning lesion as an effective method of promoting regeneration and reinnervation in an animal model, translation to the bedside until recently has been impossible due to its injurious nature (3). Our laboratory has recently identified conditioning electrical stimulation (CES) as an effective method of enhancing axonal regeneration, and improve motor and sensory reinnervation (4). Investigators of this study have further shown that CES improves regeneration and sensorimotor reinnervation beyond that attainable by postoperative CES (unpublished data). As such preoperative CES is potentially a clinically feasible method of improving patient outcomes.

Hypothesis: ES delivered prior to carpal tunnel release will improve functional outcomes in patients with severe carpal tunnel syndrome.

Research Methods: Plastic surgeons in the Division of Plastic Surgeon will identify patients with severe carpal tunnel syndrome and obtain their consent to be considered for inclusion in this study. Inclusion criteria includes patients aged over 18 years who have failed conservative treatment, who are found to have severe carpal tunnel syndrome on nerve conduction studies (thenar motor unit loss minimum two standard deviations between the mean for the age group). Exclusion criteria includes patients with pre-existing peripheral neuropathies. Patients will be randomized to three treatment groups: a) CES, b) postoperative ES, and c) no ES. Carpal tunnel release will be performed by a plastic surgeon in the standard fashion without neurolysis of the median nerve.

In clinic, skin will be cleansed with alcohol and a small gauge needle will be placed percutaneously in the proximal forearm, along the course of the median nerve based on known surface anatomy. This needle will be connected to the cathode of an SD-9 Grass stimulator. The anode will be attached to an electrical cable placed more distally on the forearm. Stimulation protocol will be based on that traditionally used for postoperative ES: 20 Hz of continuous stimulation for one hour, with voltage titrated to maximize voltage without causing patient discomfort. At the completion of one hour, the needle will be removed. One week later, carpal tunnel release will be performed by the plastic surgeon per standard technique, without neurolysis of the median nerve. Among patients receiving postoperative ES, the cathode will be placed next to the median nerve proximal to the carpal tunnel at the time of surgical release, and electrical stimulation upon completion of the surgery will follow the same stimulation parameters as outlined for CES.

Primary outcomes include sensory testing (two-point discrimination, Semmes-Weinstein monofilament, and cold threshold), motor testing (Purdue Pegboard Test), and patient-reported outcomes (Disabilities of the Arm, Shoulder and Hand questionnaire). These are well established standard testing modalities for assessing recovery following carpal tunnel release (5). Scores for two-point discrimination range from 1 to 20 mm with smaller distance reflecting better hand sensibility. Mean score for the Purdue Pegboard Test in health control is 12 pegs with a greater number reflecting better hand dexterity. Range of score for the DASH questionnaire is 0 to 100 with a higher number representing greater disability. Testing will be performed preoperatively to establish baseline sensorimotor function, then postoperatively at 3, 6, and 12 months. Outcome measures will be analyzed using two-way ANOVA, with post-hoc analysis of significant association (p<0.05).

Justification: Recovery following surgical release in severe carpal tunnel is often incomplete, with persistent motor and sensory deficits. While postoperative ES improves regeneration, functional deficits persist; however, these studies have established ES as safe and well-tolerated by patients. By changing the timing of ES from postoperative to preoperative CES, animal data suggests functional outcomes can be further improved by upregulating regenerative pathways to maximize the rate of axonal extension. As CES can be delivered percutaneously in the clinic at the initial of initial assessment, prior to surgical release, this technique is both safe, clinically feasible and may significantly improve the outcomes of patients with compression neuropathies.

Details
Condition Carpal Tunnel Syndrome
Treatment Conditioning electrical stimulation, Postoperative electrical stimulation, No electrical stimulation
Clinical Study IdentifierNCT04191538
SponsorUniversity of Alberta
Last Modified on9 May 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Severe carpal tunnel syndrome (per screening nerve conduction test - thenar motor unit loss minimum two standard deviations between the mean for the age group)
Failed conservative treatment (requires surgical intervention)

Exclusion Criteria

Preexisting neuropathy
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note